The Oxazolidinones
Author:
Publisher
Springer International Publishing
Link
http://link.springer.com/content/pdf/10.1007/7355_2017_15
Reference106 articles.
1. Brickner SJ, Barbachyn MR, Hutchinson DK, Manninen PR (2008) Linezolid (Zyvox®), the first member of a completely new class of antibacterial agents for the treatment of serious gram-positive infections. J Med Chem 51:1981–1990. doi: 10.1021/jm800038g
2. Mendes RE, Hogan PA, Jones RN, Sader HS, Flamm RK (2016) Surveillance for linezolid resistance via the Zyvox® annual appraisal of potency and spectrum (ZAAPS) programme (2014): evolving resistance mechanisms with stable susceptibility rates. J Antimicrob Chemother 71:1860–1865. doi: 10.1093/jac/dkw052
3. Mendes RE, Deshpande LM, Jones RN (2014) Linezolid update: stable in vitro activity following more than a decade of clinical use and summary of associated resistance mechanisms. Drug Resist Updates 17:1–12. doi: 10.1016/j.drup.2014.04.002
4. Burdette SD, Trotman R (2015) Tedizolid: the first once-daily oxazolidinone class antibiotic. Clin Infect Dis 61:1315–1321. doi: 10.1093/cid/civ501
5. Flanagan S, McKee EE, Das D, Tulkens PM, Hosako H, Fiedler-Kelly J, Passarell J, Radovsky A, Prokocimer P (2015) Nonclinical and pharmacokinetic assessments to evaluate the potential of tedizolid and linezolid to affect mitochondrial function. Antimicrob Agents Chemother 59:178–185. doi: 10.1128/aac.03684-14
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. New Trends on Photoswitchable Antibiotics: From Syntheses to Applications;Photocatalysis: Research and Potential;2023
2. Macrolide, lincosamide, glycopeptide, and other antibacterial antibiotics;Medicinal Chemistry of Chemotherapeutic Agents;2023
3. Recent Advances in Nonprecious Metal Catalysis;Organic Process Research & Development;2022-11-23
4. Antibiotics and Antibiotic Resistance- Flipsides of the Same Coin;Current Pharmaceutical Design;2022-08
5. Room Temperature Cu-Catalyzed N-Arylation of Oxazolidinones and Amides with (Hetero)Aryl Iodides;Organic Letters;2022-01-31
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3